Axcella Health Inc. Banner Image

Axcella Health Inc.

  • Ticker AXLA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Axcella Health Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Axcella is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company’s product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. Axcella’s pipelineMore includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence. Additional muscle- and blood-related programs are in earlier-stage development.
4.7 / 5.0 (198)

Axcella Health Inc. reports have an aggregate usefulness score of 4.7 based on 198 reviews.

Axcella Health Inc.

Most Recent Annual Report

Axcella Health Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Axcella Health Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!